PharmaSUG2023paper·China·5 Data Visualization and ReportingSimplify the safety and effectiveness research of drug development process DV-192 NanjingSee metadata
PharmaSUG2023paper·China·6 Leadership SkillsAgile team organization in pharmaceutical data science - Why we should be moving lots of small rocks rather than the one big mountain LS-109 NanjingSee metadata
PharmaSUG2023paper·China·6 Leadership SkillsYour New Role in a Cross-Function Team LS-113 NanjingSee metadata
PharmaSUG2023paper·China·6 Leadership SkillsTraveling office: How does remote working change our life of work LS-162 NanjingSee metadata
PharmaSUG2023paper·China·6 Leadership SkillsThe Relationship of Artificial Intelligence technology and Employees' employment, performance and career development: An interview based research in clinical programming area LS-167 NanjingSee metadata
PharmaSUG2023paper·China·6 Leadership SkillsProcedure Matrix: build the department assets of standardization LS-176 NanjingSee metadata
PharmaSUG2023paper·China·7 Statistics and AnalyticsProgramming Approaching for PK Analysis SA-112 NanjingSee metadata
PharmaSUG2023paper·China·7 Statistics and AnalyticsPharmacodynamics Analysis using AUC as endpoint in Single Ascending Dose Study SA-134 NanjingSee metadata
PharmaSUG2023paper·China·7 Statistics and AnalyticsResponse evaluation criteria practice for skin cancer by RECIST 1.1, or modified World Health Organization (WHO) criteria or composite criteria SA-142 NanjingSee metadata
PharmaSUG2023paper·China·7 Statistics and AnalyticsHow to better understand mRECIST – novel refinements for evaluating HCC SA-154 NanjingSee metadata
PharmaSUG2023paper·China·7 Statistics and AnalyticsAlignment between Estimand and Estimator with rbmi SA-161 NanjingSee metadata
PharmaSUG2023paper·China·7 Statistics and AnalyticsIntroduction of Matching Adjusted Indirect Comparison (MAIC) SA-182 NanjingSee metadata
PharmaSUG2023paper·China·7 Statistics and AnalyticsJumping out of Solid Tumor - Exploring Lugano 2014 in Hematologic Neoplasms Studies SA-183 NanjingSee metadata
PharmaSUG2023paper·China·8 Big Data and Real World EvidenceApplication of real-world data in clinical trial site selection and improving patient recruitment BR-170 NanjingSee metadata
PharmaSUG2023paper·China·8 Big Data and Real World EvidenceBeiGene CSM Platform – an interactive visualization dashboard for implementing Risk-Based Quality Management BR-179 NanjingSee metadata
PharmaSUG2023paper·China·9 Coder’s CornerSoftware Development Life Cycle in Developing Statistical Programming Tools CC-106 NanjingSee metadata
PharmaSUG2023paper·China·9 Coder’s CornerGeneration of Geometric Mean Titer Plot in Immunogenicity from SAS and R CC-115 NanjingSee metadata
PharmaSUG2023paper·China·9 Coder’s CornerRealize synchronized updating of SAS code by hard link CC-123 NanjingSee metadata
PharmaSUG2023paper·China·9 Coder’s CornerHow to modify a variable’s length without changing its position in dataset CC-125 NanjingSee metadata
PharmaSUG2023paper·China·9 Coder’s CornerImplementation of Cut-Off Date in Analysis of Solid tumor Clinical Trials CC-137 NanjingSee metadata